Detalhe da pesquisa
1.
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial.
Am Heart J
; 143(5): 841-6, 2002 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12040346